Adc Therapeutics SA Target Price

Explore Adc Therapeutics SA's target price with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.63

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-06-04	StephensSudan Loganathan	$5	206.7% upside
2026-06-04	RBC Capital	$2	22.7% upside
2025-12-03	RBC CapitalGregory Renza	$5	206.7% upside
2025-11-12	GuggenheimMichael Schmidt	$10	513.5% upside
2024-05-07	H.C. WainwrightRobert Burns	$8	390.8% upside
2024-03-13	JefferiesKelly Shi	$13	697.5% upside
2022-11-14	Morgan Stanley	$7	329.4% upside
2022-09-09	Morgan StanleyMatthew Harrison	$11	574.8% upside
2022-08-22	H.C. Wainwright	$20	1127% upside

Adc Therapeutics SA (ADCT) FAQ

Stockcircle tracks target price for Adc Therapeutics SA (ADCT), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Adc Therapeutics SA's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main ADCT overview so you can move from this figure to the surrounding analysis quickly.